ABOUT THIS EVENT

Impel Pharmaceuticals Inc. (Nasdaq: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Adrian Adams, Chairman and Chief Executive Officer, and members of the Board, management, and the employee base, rings the Closing Bell.